Login to Your Account



Onyx, Bayer Begin Phase III Sorafenib Trial In Melanoma

By Jennifer Boggs


Monday, May 16, 2005
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription